MiMedx Corp (MDXG) - Long-Term Debt to Capital Coefficient

MiMedx Corp - graphic logo of issuer MDXG

This chart of the current share price of MiMedx Group, Inc. (MDXG) reflects the dynamics of a company whose efficiency relies on insurance payouts and the adoption of therapies in hospitals, with the indicator standing at 0.00. The business generates revenue through the integration of placental products into surgery, which guarantees steady sales. Production is based on strict sterility and standard control over biomaterial disposal, coupled with the optimization of transport routes.

MiMedx Group Inc (MDXG): Long-Term Debt to Equity from 07/04/2022 to 10/30/2026
Signature product of MiMedx Group, Inc.

Maintaining sterility and the cold chain during the transportation of bio-implants requires significant capital expenditures on specialized infrastructure. An analysis of the long-term debt-to-equity ratio allows for an assessment of the proportion of borrowed capital with a maturity of over one year relative to asset value, demonstrating the real cost of debt service and the financial stability of MiMedx Group, Inc. (MDXG) amid inflationary pressures.

Analysis of competing companies

Ascendis Pharma AS - Long-Term Liabilities to Equity|Long-Term Debt to Capital MDGL|CORT (Corcept Therapeutics Corp) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital RYTM (Rhythm Pharmaceuticals)|Long-Term Debt to Capital akerotx.com AKRO|MTSR - Long-Term Debt to Equity|Long-Term Debt to Capital Coefficient MLTX (MoonLake Immunotherapeutics AG)|Crinetics Pharma (CRNX) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio NewAmsterdam Pharma Corp|SLNO (Soleno Therapeutics) - Long-Term Debt to Capital|Long-Term Debt to Capital amicusrx.com|Long-Term Debt to Equity Ratio ETNB (89bio)|AGIO (Agios) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Equity Structure Pharma GPCR|RZLT - Long-Term Debt to Equity Ratio|Lexicon Pharmaceuticals - Long-Term Debt to Capital|Long-Term Liabilities to Capital mbxbio.com|ALT (Altimmune) - Long-Term Debt to Equity Ratio|AARD: Long-Term Loans to Capital Ratio|SGMT (Sagimet) - Long-Term Debt to Capital|Long-Term Debt to Capital BioAge Labs, Inc|Long-Term Debt to Capital BMEA|Long-Term Debt to Equity QNCX (quincetx.com)|Long-Term Debt to Equity Fractyl Health GUTS|vTv Therapeutics, Inc. (VTVT) - Long-Term Liabilities to Capital|ATPC - Long-Term Debt to Equity|PLUR: Long-Term Debt to Equity|SYBX: Long-Term Debt to Capital|LPCN - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Matinas BioPharma Holdings, Inc.|Spruce Biosciences Inc. (SPRB) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Galecto Corp (GLTO)|Long-Term Debt to Equity Ratio Carmell Therapeutics CTCX|Long-Term Debt to Equity Lumos Pharma, Inc. LUMO|ONVO - Long-Term Debt to Equity Ratio|Radius Recycling - Long-Term Debt to Capital